The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo-Reference-Cited by-同舟云学术

The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo

Published:2011-04 Issue:10 Volume:32 Page:2673-2682
ISSN:0142-9612
Container-title:Biomaterials
language:en
Short-container-title:Biomaterials

Author:

Nguyen Ho-Ngoc,Wey Shiaw-Pyng,Juang Jyuhn-Huarng,Sonaje Kiran,Ho Yi-Cheng,Chuang Er-Yuan,Hsu Chia-Wei,Yen Tzu-Chen,Lin Kun-Ju,Sung Hsing-Wen

Publisher

Elsevier BV

Subject

Mechanics of Materials,Biomaterials,Biophysics,Ceramics and Composites,Bioengineering

Reference33 articles.

1. Isolation and characterization of exendin-4, an exendin-3 analogue, from heloderma suspectum venom;Eng;J Biol Chem,1992

2. Exenatide;Davidson;Nat Rev Drug Discov,2005

3. Pharmacology of exenatide (synthetic exendin-4): a potential therapeutic for improved glycemic control of type 2 diabetes;Nielsen;Regul Pept,2004

4. Pharmacokinetics and pharmacodynamics of exenatide following alternate routes of administration;Gedulin;Int J Pharm,2008

5. Oral delivery of peptide drugs: barriers and developments;Hamman;BioDrugs,2005

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide GLP-1 receptor agonists: From injection to oral delivery strategies;Biochemical Pharmacology;2024-11

2. Nanoparticle-Based Delivery Platforms for the Enhanced Oral Delivery of Peptides/Proteins;Therapeutic Delivery;2023-12

3. pH‐temperature Responsive Hydrogel‐Mediated Delivery of Exendin‐4 Encapsulated Chitosan Nanospheres for Sustained Therapeutic Efficacy in Type 2 Diabetes Mellitus;Macromolecular Bioscience;2023-07-06

4. Progress and prospects of polysaccharide-based nanocarriers for oral delivery of proteins/peptides;Carbohydrate Polymers;2023-07

5. Thermal stability of exenatide encapsulated in stratified dissolving microneedles during storage;International Journal of Pharmaceutics;2023-04